Area of research
Molecular Biology · Pharmacology
Research interest
Research focused on Oxidative stress and Bortezomib, with related work in Cancer research, HSF1, Oncolytic virus. Notable publications include 'Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism', 'Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression', and 'Transcription factors NRF2 and HSF1 have opposing functions in autophagy'.
Octyl itaconate enhances VSVΔ51 oncolytic virotherapy by multitarget inhibition of antiviral and inflammatory pathways
Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism
Inhibition of dual-specificity tyrosine phosphorylation-regulated kinase 2 perturbs 26S proteasome-addicted neoplastic progression
Transcription factors NRF2 and HSF1 have opposing functions in autophagy